Cited by 439HIV/AIDS Research and InterventionsHIV-related health complications and treatmentsHIV, Drug Use, Sexual Risk

Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care.

Open access
Marcus, Julia L., Chao, Chun R., Leyden, Wendy A., Xu, Lanfang, Quesenberry, Charles P., Klein, Daniel B., Towner, William J., Horberg, Michael A. +1 more·2016·JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

BACKGROUND: It is unknown if a survival gap remains between HIV-infected and HIV-uninfected individuals with access to care. METHODS: We conducted a cohort study within Kaiser Permanente California during 1996-2011, using abridged life tables to estimate the expected years of life remaining ("life expectancy") at age 20. RESULTS: Among 24,768 HIV-infected and 257,600 HIV-uninfected individuals, there were 2229 and 4970 deaths, with mortality rates of 1827 and 326 per 100,000 person-years, respectively. In 1996-1997, life expectancies at age 20 for HIV-infected and HIV-uninfected individuals were 19.1 and 63.4 years, respectively, corresponding with a gap of 44.3 years (95% confidence interval: 38.4 to 50.2). Life expectancy at age 20 for HIV-infected individuals increased to 47.1 years in 2008 and 53.1 years by 2011, narrowing the gap to 11.8 years (8.9-14.8 years) in 2011. In 2008-2011, life expectancies at age 20 for HIV-infected individuals ranged from a low of 45.8 years for blacks and 46.0 years for those with a history of injection drug use to a high of 52.2 years for Hispanics. HIV-infected individuals who initiated antiretroviral therapy with CD4 ≥500 cells per microliter had a life expectancy at age 20 of 54.5 years in 2008-2011, narrowing the gap relative to HIV-uninfected individuals to 7.9 years (5.1-10.6 years). For these HIV-infected individuals, the gap narrowed further in subgroups with no history of hepatitis B or C infection, smoking, drug/alcohol abuse, or any of these risk factors. CONCLUSIONS: Even with early treatment and access to care, an 8-year gap in life expectancy remains for HIV-infected compared with HIV-uninfected individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0000000000001014

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Effective ART that suppresses HIV replication to undetectable levels reduces morbidity, provides a near-normal lifespan, and prevents sexual transmission of HIV to others.

    “Effective ART that suppresses HIV replication to undetectable levels reduces morbidity, provides a near-normal lifespan, and prevents sexual transmission of HIV to others (95–97,410–412).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [411]

    The Discussion reports that ART substantially increased life expectancy and that earlier initiation narrowed the survival gap; it also cites lower rates of serious events with immediate ART in the START trial. But it reports a persistent gap of nearly eight years even with early ART initiation. Our copy does not establish that suppression to undetectable levels prevents sexual transmission, so the full claim is not supported by this source. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [25]Chiang CL The Life Table and its Construction. Introduction to Stochastic Processes in Biostatistics New York, NY John Wiley and Sons 1983 189 214
  2. [27]Smith DP Formal Demography New York, NY Springer Science, Business Media New York 1992
  3. [41]Horberg MA Hurley L Klein DB The HIV Care Cascade Measured Over Multiple Time Periods Varies by Race and Ethnicity Miami, FL NIMH/IAPAC Treatment Adherence Conference 2015
  4. [48]World Health Organization Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations 2014 Available at: http://apps.who.int/iris/bitstream/10665/128048/1/9789241507431_eng.pdf?ua=1&ua=1 Accessed August 25, 2015 25996019
  5. [50]Lima VD Lourenco L Yip B Trends in AIDS incidence and AIDS-related mortality in British Columbia between 1981 and 2013 Lancet HIV 2015 2 e92 e97 25780802 PMC4357843

Cited by

Sorted by citations

Authors
Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Klein, D. B., Towner, W. J., Horberg, M. A., & Silverberg, M. J.
Affiliations
  • Kaiser Permanente (US)
  • Kaiser Permanente San Leandro Medical Center (US)
Corresponding author
  • Marcus, Julia L.
  • Leyden, Wendy A.
  • Quesenberry, Charles P.
  • Silverberg, Michael J.
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2016-09-01
Volume
73
Issue
1
Pages
39-46
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2322243210
Cited by
439
References
49
Citations by year
2026: 20 · 2025: 31 · 2024: 37 · 2023: 41 · 2022: 65 · 2021: 61 · 2020: 63 · 2019: 41 · 2018: 37 · 2017: 33 · 2016: 9
FWCI
36.94
Type
journal article
Language
en
Open access
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Allergy and Infectious Diseases (K01AI122853)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Keywords
HIV, life expectancy, life expectancy gap, health care access, antiretroviral therapy, CD4 count, mortality, racial and ethnic disparities, intravenous drug use, HBV/HCV coinfection, smoking, substance abuse, Kaiser Permanente
MeSH terms
Female, Health Services Accessibility, Humans, Life Expectancy, Male, HIV Infections, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review